Updated WHO Living Guideline: Therapeutics and COVID-19.

Therapeutics and COVID-19: living guideline – World Health Organization

WHO Statement: On new recommendation for treatment of COVID-19 patients: WHO calls for equitable access to casirivimab and imdevimab for COVID-19

See also:

WHO recommends antibody treatment for COVID patients at high risk of hospital admission.

Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis – The BMJ

Commentary: WHO adds new recommendation for COVID-19 monoclonal antibody combo – CIDRAP